BIONOVO INC BNVI (NASDAQ) $ 1.05 Change: -0.08 -7.62% | Volume: 200,641

BIONOVO INC - Fundamental Profile

Company Information

Ticker Symbol: BNVI
Exchange: NASD
Contact Info: 5858 Horton Street Emeryville CA 94608 510-601-2000
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: BIONOVO INC is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women\'s health and cancer, which are markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology ofmenopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California

Share Information

Shares Outstanding: 76,340 (000) Market Value: 86,290 ($000)
Percentage of Inst.Shareholders: 8.16% Number of Inst.Shareholders: 26.30%
Last Quarter Sales: 0.00 ($Mil.) Last Quarter Net Income: -4.21 ($Mil.)
Last Quarter EPS: -0.06 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.21
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +46.20 65.06
GILEAD SCIENCES +45.50 56.26
GENENTECH INC +47.20 98.23
BIOGEN IDEC INC -1.20 54.65
CELGENE CP +36.60 75.86